These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7913478)

  • 41. The atypical antipsychotic class of psychotropic agents. Foreword.
    McIntyre RS
    Expert Opin Pharmacother; 2012 Aug; 13(11):i-ii. PubMed ID: 22774778
    [No Abstract]   [Full Text] [Related]  

  • 42. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Knowledge and expectations of direct support professionals towards effects of psychotropic drug use in people with intellectual disabilities.
    de Kuijper G; van der Putten AAJ
    J Appl Res Intellect Disabil; 2017 Dec; 30 Suppl 1():1-9. PubMed ID: 28467003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychopharmacotherapy in children and adults with intellectual disability.
    Santosh PJ; Baird G
    Lancet; 1999 Jul; 354(9174):233-42. PubMed ID: 10421318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The modern psychiatrist].
    Péter L
    Neuropsychopharmacol Hung; 2008 Oct; 10(4):179-80. PubMed ID: 19213196
    [No Abstract]   [Full Text] [Related]  

  • 46. Tom Cruise: entertaining or dangerous?
    Koplewicz HS
    J Child Adolesc Psychopharmacol; 2005 Jun; 15(3):iii. PubMed ID: 16092899
    [No Abstract]   [Full Text] [Related]  

  • 47. Legal issues in the assessment and treatment of individuals with dual diagnoses.
    Bersoff DN; Glass DJ; Blain N
    J Consult Clin Psychol; 1994 Feb; 62(1):55-62. PubMed ID: 8034829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Olanzapine-induced neuroleptic malignant syndrome with mental retardation.
    Margolese HC; Chouinard G
    Am J Psychiatry; 1999 Jul; 156(7):1115-6. PubMed ID: 10401467
    [No Abstract]   [Full Text] [Related]  

  • 49. Support staff's perceptions of discontinuing antipsychotics in people with intellectual disabilities in residential care: A mixed-method study.
    Kleijwegt B; Pruijssers A; de Jong-Bakker L; de Haan K; van Os-Medendorp H; van Meijel B
    J Appl Res Intellect Disabil; 2019 Jul; 32(4):861-870. PubMed ID: 30790388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors associated with psychotropic medication in mental retardation facilities.
    Tu J; Smith JT
    Compr Psychiatry; 1979; 20(3):289-95. PubMed ID: 446009
    [No Abstract]   [Full Text] [Related]  

  • 51. Rational use and rationale for use: psychiatric medication at an Argentine institution for intellectual disability.
    de Menil V; Cohen A
    Transcult Psychiatry; 2009 Dec; 46(4):651-71. PubMed ID: 20028682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug treatment modalities in psychiatric inpatient practice: a 20-year comparison.
    Barbui C; Ciuna A; Nosè M; Levi D; Andretta M; Patten SB; Amaddeo F; Tansella M
    Eur Arch Psychiatry Clin Neurosci; 2005 Apr; 255(2):136-42. PubMed ID: 15812608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs.
    Scheifes A; Walraven S; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
    Res Dev Disabil; 2016; 49-50():13-21. PubMed ID: 26647003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychotropic medication use in children and adolescents in an inpatient setting.
    Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
    Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A survey of psychotropic medication in mental retardation facilities.
    Tu JB
    J Clin Psychiatry; 1979 Mar; 40(3):125-8. PubMed ID: 33967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outpatient psychotherapy for adults with mental retardation and concomitant psychopathology: research and clinical imperatives.
    Nezu CM; Nezu AM
    J Consult Clin Psychol; 1994 Feb; 62(1):34-42. PubMed ID: 8034826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Out-of-area provision for adults with intellectual disabilities and challenging behaviour in England: policy perspectives and clinical reality.
    Barron DA; Hassiotis A; Paschos D
    J Intellect Disabil Res; 2011 Sep; 55(9):832-43. PubMed ID: 21554465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute inpatient treatment, hospitalization course and direct costs in bipolar patients with intellectual disability.
    Wu CS; Desarkar P; Palucka A; Lunsky Y; Liu SK
    Res Dev Disabil; 2013 Nov; 34(11):4062-72. PubMed ID: 24051362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of neuropsychiatric symptoms in dementia.
    Friedman M
    Med Health R I; 2012 Jul; 95(7):212-3. PubMed ID: 22928233
    [No Abstract]   [Full Text] [Related]  

  • 60. The overweight: obesity and plasma lipids in adults with intellectual disability and mental illness.
    Gazizova D; Puri BK; Singh I; Dhaliwal R
    J Intellect Disabil Res; 2012 Sep; 56(9):895-901. PubMed ID: 21883600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.